Deals & Corporate Governance

  • January 16, 2024

    Union Funds Drop Suit Against CIA Janitorial Contractors

    Two union benefit funds have dropped their federal lawsuit against a pair of companies that staff janitorial workers and security guards at the Central Intelligence Agency's headquarters, agreeing in a stipulation of dismissal docketed Tuesday to stop pursuing claims that the companies withheld financial documents from fund-retained auditors.

  • January 16, 2024

    Crowell Adds Moses Singer Health Trio In New NYC Office

    Crowell & Moring LLP announced Tuesday that it has hired a team from Moses & Singer LLP with rare expertise in regulatory and compliance issues related to clinical trials for biotech and health tech companies.

  • January 12, 2024

    UPenn Health System Eyes Merger With Ailing Hospital

    The University of Pennsylvania Health System has announced plans to acquire Doylestown Health in a deal that aims to increase its competitive footprint in the Philadelphia area.

  • January 12, 2024

    Taxation With Representation: Kirkland, Latham, Wachtell

    In this week's Taxation With Representation, Chesapeake Energy and Southwestern Energy announce a merger, Hewlett Packard Enterprise acquires Juniper Networks, Johnson & Johnson buys Ambrx Biopharma Inc., and Boston Scientific Corp. purchases Axonics Inc.

  • January 11, 2024

    2nd Circ. Hears UnitedHealth Office-Based Surgery Fight

    A Second Circuit panel was told Thursday that a lower court erred when it found UnitedHealth Group Inc. and related companies didn't violate federal benefits law by not paying facility fees to out-of-network, office-based surgery providers.

  • January 11, 2024

    Wash. Justice Flags Class Action 'Weakness' In Wage Claim

    Washington's high court debated Thursday whether U.S. Supreme Court precedent on class actions required the revival of a nurse's wage-theft suit, with one justice noting a "weakness" in the case because it was not itself a class action.

  • January 11, 2024

    Activist Firm Sets Off Board Challenge At Healthcare REIT

    Hedge fund Land & Buildings Investment Management LLC has nominated three candidates to healthcare real estate investment trust Ventas Inc.'s board of directors, the REIT said Thursday, which kicks off a fight for power at a company Land & Buildings has leveled criticism at for over two years.

  • January 11, 2024

    Medtech Co. Integer To Buy Pulse Technologies For $140M

    Medical device manufacturer Integer Holdings Corp. announced Wednesday that it has acquired private engineering and contract manufacturing company Pulse Technologies Inc. for around $140 million.

  • January 10, 2024

    Union Funds Exit Amgen, Teva Antitrust MDL

    Teva Pharmaceuticals has settled its differences with the union funds making up the indirect purchase class in multidistrict litigation accusing it of hatching an illegal deal to remove a generic calcium-control drug from the market.

  • January 10, 2024

    US Trustee Calls SmileDirect Ch. 11 Deal An Improper Plan

    The Office of the United States Trustee objected Wednesday to a global settlement proposed by bankrupt teledentistry company SmileDirectClub Inc., saying it amounts to an impermissible sub rosa plan that wouldn't cover the administrative costs of the Chapter 11 case prior to its dismissal.

  • January 10, 2024

    CNS Startup Myrobalan Therapeutics Raises $24M Series A

    Biotech company Myrobalan Therapeutics announced Wednesday it has raised a $24 million series A to develop treatments for degenerative CNS conditions.

  • January 09, 2024

    FTC Blocked IQVIA On Old Threshold, Without 'Rubber Stamp'

    The judge who temporarily blocked the merger between healthcare data company IQVIA and Propel Media shortly before it was abandoned insisted in his newly published federal court ruling that his decision wasn't a "rubber stamp" of the Federal Trade Commission's request to halt the deal.

  • January 09, 2024

    VC Firm Expands Collaborations In New Tech Initiative Debut

    Biotech venture capital firm Flagship Pioneering announced expanded collaborations with Samsung C&T Corp. and Thermo Fisher Scientific Inc. on Monday, as part of a larger initiative focused on fostering "enabling technologies" for the life sciences, during the J.P. Morgan Healthcare Conference in San Francisco.

  • January 09, 2024

    Biopharma Co. Can't Dodge Secrets Row Over Detox Drug

    A Florida federal judge has refused to throw out a suit from GBB Drink Lab Inc. claiming FSD Biosciences flouted a nondisclosure agreement relating to a blood-alcohol detoxification product.

  • January 09, 2024

    GSK Agrees To Buy US Respiratory Drug Biz For Up To $1.4B

    GSK said Tuesday that it has agreed to buy Aiolos Bio Inc., a clinical-stage asthma drug developer, in a deal that could reach $1.4 billion as the British pharmaceuticals giant looks to grow its portfolio of respiratory treatments.

  • January 08, 2024

    Merck Lands Cancer Fighter Harpoon Therapeutics For $680M

    Merck has entered into an agreement to acquire Harpoon Therapeutics, a cancer immunotherapy company founded eight years ago, for $23 per share in cash for an approximate total equity value of $680 million, the companies said Monday.

  • January 08, 2024

    Novartis To Buy Merck Spin-Off Calypso Biotech For Up To $375M

    Swiss pharmaceutical giant Novartis is buying European company Calypso Biotech in a deal that could be worth up to $375 million, according to an announcement from Calypso on Monday, marking one of the earliest deals to be announced at the start of the deal frenzy expected at the J.P. Morgan Healthcare conference in San Francisco this week.

  • January 08, 2024

    Eli Lilly, Novartis Could Pump Close To $3B Into AI Drug Tech

    Eli Lilly & Co. and Novartis could invest close to $3 billion in the development of artificial intelligence for drug discovery under two new agreements with a digital biology company owned by Google's parent company.

  • January 08, 2024

    Cravath Steers J&J Buy Of Skadden-Led Ambrx In $2B Deal

    Pharmaceutical industry giant Johnson & Johnson, advised by Cravath Swaine & Moore LLP, is buying San Diego, California-based clinical-stage biopharmaceutical company Ambrx Biopharma Inc., advised by Skadden Arps Slate Meagher & Flom LLP, in an all-cash, take-private deal with a total equity value of roughly $2 billion, the two companies announced separately Monday.

  • January 05, 2024

    Pharma Co. Snags $100M To Advance Psychedelic Treatment

    The pharmaceutical arm of the nonprofit Multidisciplinary Association for Psychedelic Studies said on Friday it raised $100 million in an initial round of financing as it transitions to new leadership.

  • January 05, 2024

    ​​Boehringer Ingelheim Inks €410M Deal With Kyowa Kirin

    Pharmaceutical giant Boehringer Ingelheim announced Friday that it had entered into a €410 million ($449 million) licensing agreement with Japanese pharmaceutical company Kyowa Kirin to develop a new treatment for fibro-inflammatory diseases, the third in a string of consecutive deals Boehringer Ingelheim has announced this week.

  • January 05, 2024

    Md. Retirees Ask 4th Circ. For 2nd Shot At Drug Coverage Suit

    Retired Maryland state employees have asked the Fourth Circuit for another chance to pursue a proposed class action over the state's transition of their prescription coverage plan to Medicare Part D after their first try was dismissed last year.

  • January 05, 2024

    9th Circ. Won't Rethink FCA Disclosure Ruling Against Valeant

    A Ninth Circuit panel on Friday denied drugmaker Valeant Pharmaceuticals' request to review its decision to revive a False Claims Act suit accusing Valeant of fraudulently obtaining a patent to extend its monopoly on the drug Apriso.

  • January 05, 2024

    Attys Hopeful For Deals Pickup As JPMorgan Event Kicks Off

    Attorneys heading to the annual J.P. Morgan Healthcare Conference are hoping to strike fruitful conversations with other dealmakers regarding capital-raising and M&A prospects, aided by the backdrop of several blockbuster acquisitions in recent weeks.

  • January 05, 2024

    NC Residents Bemoan Holdups In Hospital Monopoly Case

    A group of North Carolina residents are pushing the state Business Court to move ahead with discovery in their antitrust suit against Mission Hospital and its new owners, saying the case shouldn't have to idle while they wait for a long-delayed ruling in parallel federal litigation.

Expert Analysis

  • Interstate Cannabis Commerce May Be In Reach, With Caveats

    Author Photo

    California is the latest state to lay the groundwork for interstate cannabis commerce agreements, which may offer a solution to the overabundance of product in legal adult-use markets and survive constitutional challenges — but even then, obstacles to a national market will remain, say Adam Horowitz and Harry Berezin at Goodwin.

  • Without Stronger Due Diligence, Attys Risk AML Regulation

    Author Photo

    Amid increasing pressure to mitigate money laundering and terrorism financing risks in gatekeeper professions, the legal industry will need to clarify and strengthen existing client due diligence measures — or risk the federal regulation attorneys have long sought to avoid, says Jeremy Glicksman at the Nassau County District Attorney’s Office.

  • Abortion Pill Rulings Will Hinder FDA Authority

    Author Photo

    Although the Fifth Circuit recently stayed a Texas federal court's ruling that invalidated the U.S. Food and Drug Administration's approval of a commonly used abortion medication, several points made by the courts are worth considering for their potentially chilling effect on FDA authority and the challenges they may create for the life sciences industry, say attorneys at Morgan Lewis.

  • Cannabis Labor Peace Laws Lay Fertile Ground For Unions

    Author Photo

    State legislatures are increasingly passing cannabis laws that encourage or even mandate labor peace agreements as a condition for licensure, and though open questions remain about the constitutionality of such statutes, unionization efforts are unlikely to slow down, says Peter Murphy at Saul Ewing.

  • Every Lawyer Can Act To Prevent Peer Suicide

    Author Photo

    Members of the legal industry can help prevent suicide among their colleagues, and better protect their own mental health, by learning the predictors and symptoms of depression among attorneys and knowing when and how to get practical aid to peers in crisis, says Joan Bibelhausen at Minnesota Lawyers Concerned for Lawyers.

  • Building On Successful Judicial Assignment Reform In Texas

    Author Photo

    Prompt action by the Judicial Conference could curtail judge shopping and improve the efficiency and procedural fairness of the federal courts by implementing random districtwide assignment of cases, which has recently proven successful in Texas patent litigation, says Dabney Carr at Troutman Pepper.

  • Now Is The Time For Independent Industry Self-Regulation

    Author Photo

    The high level of trust in business, coupled with the current political and legal landscape, provides an opportunity for companies to play a meaningful role in finding solutions to public policy issues through the exploration of independent industry self-regulation models, says Eric Reicin at BBB National Programs.

  • AmEx Ruling Proves A Double-Edged Sword In Labor Antitrust

    Author Photo

    Though the U.S. Supreme Court's 2018 decision in Ohio v. American Express was a defense victory, both the plaintiff and defense bars have learned to use the case's holdings to their advantage, with particularly uncertain implications for labor antitrust cases, say Lauren Weinstein and Robert Chen at MoloLamken.

  • Do Videoconferences Establish Jurisdiction With Defendants?

    Author Photo

    What it means to have minimum contacts in a foreign jurisdiction is changing as people become more accustomed to meeting via video, and defendants’ participation in videoconferencing may be used as a sword or a shield in courts’ personal jurisdiction analysis, says Patrick Hickey at Moye White.

  • Takeaways From DOJ's Novel Insider Trading Indictment

    Author Photo

    The U.S. Department of Justice's recently announced insider trading charges in U.S. v. Peizer mark the first indictment based solely on an executive’s use of a Rule 10b5-1 trading plan, reflecting prosecutors' aggressive approach and providing insights for corporate executives, say attorneys at Cleary.

  • Humanism Should Replace Formalism In The Courts

    Author Photo

    The worrying tendency for judges to say "it's just the law talking, not me" in American decision writing has coincided with an historic decline in respect for the courts, but this trend can be reversed if courts develop understandable legal standards and justify them in human terms, says Connecticut Superior Court Judge Thomas Moukawsher.

  • Expect Merger Enforcement To Roll Full Steam Ahead

    Author Photo

    U.S. Department of Justice and Federal Trade Commission officials at the American Bar Association's 2023 Antitrust Spring Meeting laid out their agenda to reinvigorate and modernize antitrust merger enforcement, projecting confidence and optimism despite recent high-profile setbacks in court, say attorneys at Perkins Coie.

  • Don't Let Client Demands Erode Law Firm Autonomy

    Author Photo

    As clients increasingly impose requirements for attorney hiring and retention related to diversity and secondment, law firms must remember their ethical duties, as well as broader issues of lawyer development, culture and firm integrity, to maintain their independence while meaningfully responding to social changes, says Deborah Winokur at Cozen O'Connor.